Curexo Inc. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
31,091
26,138
27,530
30,061
33,484
Cost of Goods Sold (COGS) incl. D&A
27,924
22,897
26,956
28,612
27,925
Gross Income
3,167
3,241
573
1,448
5,559
SG&A Expense
17,158
23,922
25,239
41,950
4,998
EBIT
14,041
20,733
24,759
40,603
556
Unusual Expense
4
197
-
3,065
-
Non Operating Income/Expense
115
621
197
44,865
259
Interest Expense
78
811
136
625
87
Pretax Income
14,157
22,267
25,016
616
16,885
Equity in Affiliates
437
-
-
1,991
-
Consolidated Net Income
14,595
22,267
25,017
1,375
16,885
Net Income
7,465
10,859
9,402
24,151
16,885
Net Income After Extraordinaries
7,465
10,859
9,402
24,151
16,885
Net Income Available to Common
7,465
10,859
9,402
24,151
16,885
EPS (Basic)
267.58
388.51
336.14
864.63
586.58
Basic Shares Outstanding
28
28
28
28
29
EPS (Diluted)
267.18
388.65
336.51
864.36
586.99
Diluted Shares Outstanding
28
28
28
28
29
EBITDA
13,249
19,452
22,851
37,412
865
Other Operating Expense
50
51
93
102
4
Non-Operating Interest Income
81
95
77
44
50
Minority Interest Expense
7,130
11,408
15,614
25,526
-
Equity in Affiliates (Pretax)
-
-
-
-
17,146
About Curexo
View Profile
